PASG Passage Bio
- 1.340
- 0.0000.00%
Passage Bio News
Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
Passage Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)
Passage Bio Earns Buy Rating Based on Robust Financial Position and Promising AAV1-based GT PBFT02 Trial
Raymond James Maintains Outperform on Passage Bio, Lowers Price Target to $5
Passage Bio Analyst Ratings
Wedbush Lowers Passage Bio's Price Target to $3 From $5, Maintains Outperform Rating
Chardan Capital Maintains Buy on Passage Bio, Lowers Price Target to $9
Passage Bio Analyst Ratings
Passage Bio (PASG) Gets a Buy From Chardan Capital
Raymond James Trims Price Target on Passage Bio to $9 From $10, Keeps Outperform Rating
Raymond James Maintains Outperform on Passage Bio, Lowers Price Target to $9
Goldman Sachs Reaffirms Their Hold Rating on Passage Bio (PASG)
Passage Bio (PASG) Gets a Buy From BTIG
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Guardant Health (GH) and Passage Bio (PASG)
Chardan Cuts Price Target on Passage Bio to $11 From $18, Keeps Buy Rating
Guggenheim Maintains Buy on Passage Bio, Lowers Price Target to $11
Wedbush Trims Passage Bio's Price Target to $5 From $6, Keeps Outperform Rating
Canaccord Genuity Initiates Coverage On Passage Bio With Buy Rating, Announces Price Target of $8
Analysis
Price Target
No Data
